Neuroprotection by the pyridoindole stobadine: A minireview

Brain Research Bulletin

Volumn 42, Issue 5, 1997, Pages 335-340

  Stolc S ^a   Vlkolinsky R ^a   Pavlasek J ^b  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Antioxidant; Brain; Free radical scavenger; Ischemia; Spinal cord; Stroke

Indexed keywords

ALKADIENE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA TOCOPHEROL; CARBOLINE DERIVATIVE; FREE RADICAL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOLIPID; SCAVENGER; STOBADINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOG; DRUG PENETRATION; HIPPOCAMPUS; HYPOXIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REOXYGENATION; REPERFUSION; REVIEW; SURVIVAL; SYMPATHETIC GANGLION;

EID: 0030895408     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00294-8     Document Type: Article

References (55)

1. Beckman J. S., Liu T. S., Hogan E. L., Lindsay S. L., Freeman B. A., Hsu C. Y. Evidence for role of oxygen radicals in cerebral ischemic injury. Ginsberg M. D., Dietrich W. D. Cerebrovascular diseases. 1989;373-379 Raven Press, New York.
2. Beneš L., Štol S. Stobadine. Drugs Future. 14:1989;135-137.
3. Beneš L., Pronayová N. Free radical scavenger prodrugs - Potentially potent brain penetrating agents. Pharmazie. 49:1994;69-70.
4. Braughler J. M., Hall E. D. Central nervous system trauma and stroke I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic. Biol. Med. 6:19889;289-301.
5. Chan P. H. Oxygen radicals in focal cerebral ischemia. Brain Pathol. 4:1994;59-65.
6. Clemens J. A., Saunders R. D., Ho P. P., Phebus L. A., Pannetta J. A. The antioxidant LY231617 reduces global ischemic neuronal injury in rats. Stroke. 24:1993;716-723.
7. Clemens J. A., Pannetta J. A. Free radicals in central nervous system diseases. Blake D., Winyar P. G. Immunopharmacology of free radical species. 1995;73-83 Academic Press, London.
8. 3H-stobadine in the rat brain (in Slovak). In: Abstracts from XIVth Biochemical Conference. Bratislava, Slovak Republic: Slovak Technical University; 1995:113.
9. Fisher M., Jone S., Sacc R. L. Prophylactic neuroprotection for cerebral ischemia. Stroke. 25:1994;1075-1080.
10. Floyd R. A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J. 4:1990;2587-2597.
11. Hall E. D. Free radicals in central nervous system injury. Rice-Evans C. A.\, Burdon R. H. Free radical damage and its control. 1994;217-238 Elsevier Science B.V. Amsterdam.
12. Hall E. D., Braughler J. M. Central nervous system trauma and stroke II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic. Biol. Med. 6:1989;303-313.
13. Hall E. D., Braughler J. M., Yonkers P. A., Smith S. L., Linseman K. L., Means E. D., Scherch H. M., Von Voigtlander P. F., Lahti R. A., Jacobsen E. J. U-78517F: A potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J. Pharmacol. Exp. Ther. 258:1991;688-694.
14. Halliwell B. Oxidants and the central nervous system: Some fundamental questions. Acta Neurol. Scand. 126:1989;23-33.
15. Halliwell B. Lipid peroxidation, free-radical reactions and human disease. Current concepts. 1991;MI: Upjohn, Kalamazoo.
16. Halliwell B., Gutteridg J. M. Role of free radicals and catalytic metal ions in human disease. An overview. Packer L., Glazer A. N. Oxygen radicals in biological systems, part B., Oxygen radicals and antioxidants. Methods in enzymology. 186:1990;1-88 Academic Press, San Diego.
17. Hara H., Sukamot T., Kogur K. Mechanism and pathogenesis of ischemia-induced neuronal damage. Prog. Neurobiol. 40:1993;645-670.
18. Horáková L'., Lukovič L'., Štol S. Effect of stobadine and vitamin E on the ischemic reperfused brain tissue. Pharmazie. 45:1990;223-224.
19. Horáková L., Juráne I., Bokníková B. Antioxidative effect of stobadine on lipid peroxidation of rat brain mitochondria. Biológia (Bratislava). 45:1990;313-318.
20. Horáková L'., Uraz V., Ondrejičková O., Lukovič L'., Juráne I. Effect of stobadine on brain lipid peroxidation induced by incomplete ischemia and subsequent reperfusion. Biomed. Biochim. Acta. 50:1991;1019-1025.
21. Horáková L'., Ondrejičková O., Uraz V., Lukovič L'., Juráne I. Short cerebral ischemia and subsequent reperfusion and treatment with stobadine. Experientia. 48:1992;872-874.
22. Horáková L'., Sie H., Steenke S. Antioxidant action of stobadine. Methods Enzymol. 234:1994;572-580.
23. Horáková L'., Schau R. J., Balgavý P., Egger G. Interaction of the pyridoindole stobadine with alkoxyl and stable free radicals. Redox Report. 1:1995;369-372.
24. Jones D. P. The role of oxygen concentration in oxidative stress. Hypoxic and hyperoxic models. Sies H. Oxidative stress. 1985;151-195 Academic Press, London.
25. Kagan V. E., Tsuchyia M., Serbinov E., Packe L., Sies H. Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals. Biochem. Pharmacol. 45:1993;393-400.
26. Kállay Z., Bittererová J., Brejch A., Faberová V., Bezek Š., Trnove T. Plasma concentration, tissue distribution and excretion of the prospective cardioprotective agent cis-(-)-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido-[4,3-b]indole dihydrochloride in rats. ArzneimittelForschung/Drug Res. 40:1990;974-979.
27. Kaplán P., Rača P., Lehotský J., Mézešová V. Change in fluidity of brain endoplasmic reticulum membranes by oxygen free radicals: A protective effect of stobadine, α -tocopherol acetate, and butylated hydroxytoluene. Neurochem. Res. 20:1995;815-820.
28. Kaplán P., Rača P., Matejovičová M., Lehotský J., Drgová H., Mézešová V. Effect of free oxygen radicals on functional and physical properties of brain membranes. Protective properties of stobadine (in Slovak). Abstracts from XIVth Biochemical Conference. 1995;183 Slovak Technical University, Bratislava, Slovak Republic.
29. Kvaltínová Z., Lukovič L'., Štol S. Effect of incomplete ischemia and reperfusion of the rat brain on the density and affinity of α -adrenergic binding sites in the cerebral cortex. Prevention of changes by stobadine and vitamin E. Neuropharmacology. 32:1993;785-791.
30. Kvaltínová Z., Štol S. Effect of stobadine on N-methyl-D-aspartate binding sites in rat hippocampus under oxidative stress. Abstracts from 9th Noordwijkerhout-Camerino Symposium Trends in Drug Research. 1993;29 Vrije Universiteit, Noordwijkwerhout, The Netherlands.
31. Kvaltínová Z., Štol S. Decrease of the density of NMDA binding sites in rat hippocampal slices under oxidative stress: Pharmacological analysis. Can. J. Physiol. Pharmacol. 72:((Suppl. 1)):1994;438.
32. Kvaltínová Z., Štol S. NMDA binding sites in rat hippocampus under oxidative stress: Effect of antioxidants and NMDA antagonists. Receptor classification. Abstracts. 1995;32 GLAXO SpA, Verona, Italy.
33. Kvaltínová Z., Štol S. Further studies on the action of stobadine during oxidative stress in rat hippocampus. MEFA '95 Congress, Abstracts. 1995;176 Brno Trade Fairs and Exhibitions Co., Ltd, Brno, Czech Republic.
34. Kvaltínová, Z.; Štol, S. NMDA binding sites in rat hippocampus under oxidative stress: Effect of antioxidants and NMDA antagonists. In: Ann. NY Acad.Sci. (in press).
35. Lesiuk H., Sutherlan G., Peelin J., Butle K., Saunders J. Effect of U74006F on forebrain ischemia in rats. Stroke. 22:1991;896-901.
36. Lukáčová N., Chavk M., Halá G. Effect of stobadine on lipid peroxidation and phospholipids in rabbit spinal cord after ischaemia. Neuropharmacology. 32:1993;235-241.
37. Lysko P. G., Feuerstein G. Z., Ruffollo R. R. Jr. Carvedilol - A novel multiple action antihypertensive drug. Pharmaceut. News. 2:1995;12-16.
38. Maruki Y., Koehler R. C., Kirsch J. R., Blizzard K. K., Traystman R. J. Effect of 21-aminosteroid tirilazad on cerebral pH and somatosensory evoked potentials after incomplete ischemia. Stroke. 24:1993;724-730.
39. Matejovičová M., Kaplá P., Mézešová V. Synaptosomal plasma membrane from gerbil's brain during oxidative stress in vitro and protective effect of the stobadine. 1995 Annu. Meet. of the Austrian Neurosci. Assoc. 1995;72 Karl-Franzens University, Graz, Austria.
40. Ondriaš K., Hromadová M. Antiarrhythmic-antihypoxic drug stobadine inhibits copper-induced peroxidation of low density lipoprotein. Pharmazie. 47:1992;392.
41. Pavlásek J., Haburčá M., Mašánová C., Štol S. Transport of an antihypoxic drug stobadine across the blood-brain barrier in rat striatum and its influence on catecholamine-oxidative current: A voltammetric study under normal and anoxic/ischemic conditions. Physiol. Res. 45:1996;193-204.
42. Perkins W. J., Milde L. N., Milde J. H., Michenfelder J. D. Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs. Stroke. 22:1991;902-909.
43. Pomfy M., Nicá A., Mojžiš J., Húsk J., Beneš L. Experimental studies of some microrheological factors in serious brain ischemia after stobadine pretreatment. Mol. Chem. Neuropathol. 25:1995;115-122.
44. Pomfy M., Frank J., Nováková B., Maršal J., Škub J. Effect of stobadine on survival, histopathologic outcome and acid-base status after global brain ischemia in dogs. J. Brain Res. 36:1995;365-378.
45. 2+-transport and protection by stobadine. Biochem. Mol. Biol. Int. 36:1995;569-577.
46. Rosenbaum D. M., Kalberg J., Kessle J. A. Superoxide dismutase ameliorates neuronal death from hypoxia in culture. Stroke. 25:1994;857-863.
47. Sies H. Zur Biochemie der Thiolgruppe: Bedeutung des Glutathions. Naturwissenschaften. 76:1989;57-64.
48. Štefek M., Masaryková M., Beneš L. Inhibition of cumene hydroperoxide-induced lipid peroxidation by novel pyridoindole antioxidant in rat liver microsomes. Pharmacol. Toxicol. 70:1992;407-411.
49. Štolc S., Horáková L'. Effect of stobadine on postischemic lipid peroxidation in the rat brain. Bartko D., Turčán P., Stern G. New trends in clinical neuropharmacology. 1988;59-63 John Libbey and Co. Ltd, London.
50. Štolc S. Pyridoindole stobadine is a nonselective inhibitor of voltage-operated ion channels in rat sensory neurons. Gen. Physiol. Biophys. 13:1994;259-266.
51. Štolc S. Pyridoindole stobadine protects sympathetic ganglion against hypoxia-reoxygenation injury: A comparison with Trolox® Pharmacol. Commun. 4:1994;277-284.
52. Štolc S., Selecká J. Protective effect of stobadine, a pyridoindole antioxidant, in hypoxia-reoxygenation injury of ganglionic and hippocampal neurotransmission. Mol. Chem. Neuropathol. 25:1995;199-212.
53. Štolc S., Vlkolinský R. Neurotransmission during hypoxia and reoxygenation in vitro: Pharmacological protection. Pharmacol. Res. Suppl. 31:1995;295.
54. Yasuda H., Nakajim A. Brain protection against ischemic injury by nizofenone. Cerebrovasc. Brain Metabol. Rev. 5:1993;264-276.
55. Yoshida S., Bustr R., Watso B. D., Santiso M., Ginsber M. D. Postischemic cerebral lipid peroxidation in vitro: Modification by dietary vitamin. E. J. Neurochem. 44:1985;1593-1601.